← Leaderboards
Joseph C Loftus
Mayo Clinic Coll Of Med, Mayo Clinic Az
$6,305,672
Attributed
$6,305,672
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $988.8K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$6,305,672 · 5
By mechanism
R01$5,627,811 · 4
P50$677,861 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Insight”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- James Dennis Neaton · Northwestern University$283,212,546
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$278,513,775
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$200,435,757
Research focus
InsightRadiationCellsGlioblastomaGliomaResistanceBaseSignal TransductionIntegrinsRegulationCessation Of LifeExcisionCell ProliferationTumorIn VivoNovel TherapeuticsBrainCell MotilityXenograft ModelTemozolomideChemotherapyLinkAdultMalignant - Descriptor
Grant awards (21)
Role of a Novel TROY-EGFR Complex in Gliobastoma Invasion and Resistance$385,001
R01 · FY2019 · NS · contact PI
Role of a Novel TROY-EGFR Complex in Gliobastoma Invasion and Resistance$385,001
R01 · FY2018 · NS · contact PI
HTS for Identification of Novel Inhibitors of Pyk2 Activity$406,260
R01 · FY2017 · CA · contact PI
Role of a Novel TROY-EGFR Complex in Gliobastoma Invasion and Resistance$385,001
R01 · FY2017 · NS · contact PI
HTS for Identification of Novel Inhibitors of Pyk2 Activity$412,894
R01 · FY2016 · CA · contact PI
Role of a Novel TROY-EGFR Complex in Gliobastoma Invasion and Resistance$385,001
R01 · FY2016 · NS · contact PI
HTS for Identification of Novel Inhibitors of Pyk2 Activity$436,028
R01 · FY2015 · CA · contact PI
Role of a Novel TROY-EGFR Complex in Gliobastoma Invasion and Resistance$401,501
R01 · FY2015 · NS · contact PI
Histone Modification and GBM Therapy$151,283
P50 · FY2015 · CA · contact PI
Histone Modification and GBM Therapy$133,829
P50 · FY2014 · CA · contact PI
Identification and Targeting of Mediators of Glioma Invasion$192,174
P50 · FY2013 · CA · contact PI
Identification and Targeting of Mediators of Glioma Invasion$200,575
P50 · FY2012 · CA · contact PI
FAK and Pky2 in Determination of Glioblastoma Phenotype$263,952
R01 · FY2009 · CA · contact PI
FAK and Pky2 in Determination of Glioblastoma Phenotype$264,504
R01 · FY2008 · CA · contact PI
FAK and Pky2 in Determination of Glioblastoma Phenotype$261,027
R01 · FY2007 · CA · contact PI
FAK and Pky2 in Determination of Glioblstoma Phenotype$269,087
R01 · FY2006 · CA · contact PI
FAK and Pky2 in Determination of Glioblastoma Phenotype$294,554
R01 · FY2005 · CA
Role of Integrins in Cardiac Myocyte Function$269,500
R01 · FY2004 · HL
Role of Integrins in Cardiac Myocyte Function$269,500
R01 · FY2003 · HL
Role of Integrins in Cardiac Myocyte Function$269,500
R01 · FY2002 · HL
Role of Integrins in Cardiac Myocyte Function$269,500
R01 · FY2001 · HL